The adipogenesis inhibition mechanisms of simvastatin remain unclear, but this HMG-CoA reductase inhibitor is widely used to lower LDL-C in patients with hyperlipidemia and cardiovascular diseases. Here, HMGCR is linked to cardiovascular disorder.